Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2024 Investor Conference Call
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, is set to host an investor conference call to discuss the results for its fourth quarter and fiscal year 2024. The conference call is scheduled to take place on Thursday, June 20, 2024, at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time.
The Company will unveil its financial results for the fourth quarter fiscal year 2024 before the markets open on the same day. Miguel Martin, Chief Executive Officer, and Simona King, Chief Financial Officer, will be leading the conference call and the question and answer session.
Aurora Cannabis, headquartered in Edmonton, Alberta, is a pioneer in the global cannabis industry, catering to both the medical and consumer markets across Canada, Europe, Australia, and South America. The Company’s adult-use brand portfolio includes popular brands like Drift, San Rafael ’71, Daily Special, Tasty’s, Being, and Greybeard. On the medical cannabis side, Aurora offers brands such as MedReleaf, CanniMed, and Whistler Medical Marijuana Co.
Aurora’s common shares trade on the NASDAQ and TSX under the symbol “ACB”. The Company is known for its commitment to high-quality cannabis products and innovation in the industry.
The conference call aims to provide investors and stakeholders with insights into Aurora Cannabis’ performance for the fourth quarter and fiscal year 2024. Stay tuned for more updates following the conference call on June 20, 2024.
